Rova-T Program Ended in Small Cell Lung Cancer

Rova-T Program Ended in Small Cell Lung Cancer - OncLive

- August 31, 2019

Rova-T Program Ended in Small Cell Lung Cancer OncLive

AbbVie has officially ended its rovalpituzumab tesirine (Rova-T) research and development program, which was exploring the antibody-drug conjugate in ...

Search This Blog

Lung Cancer

Rova-T Program Ended in Small Cell Lung Cancer - OncLive

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times